7 medical device manufacturing trends in 2026

April 6, 2022. 9 mins read

Medical device manufacturing is becoming more complex, connected and data led. Global medical device revenue is projected to grow at a compound annual growth rate of 5.84% between 2026 and 2030, reflecting continued demand across diagnostics, cardiology, surgical technologies and connected care [1]. In Europe, the medical technology market was estimated at around €170 billion in 2024, with more than 930,000 direct employees and over 38,000 medical technology companies, 90% of which are SMEs [2].

This growth is creating new operational requirements for manufacturers. Products are becoming more connected, production environments are becoming more digital and regulatory expectations are now tied more closely to quality, cybersecurity and traceability. Manufacturers need to assess how each investment supports production continuity, compliance and long-term asset performance.

The manufacturers best placed to succeed in 2026 will not simply adopt more technology. They will assess whether each investment improves quality, resilience, compliance or production performance.

What to keep on your radar

AI is moving into inspection, maintenance, design and documentation, but validation remains essential.
Smart manufacturing improves traceability and visibility, particularly when production data is reliable.
Connected devices increase cybersecurity, interoperability and software bill of materials requirements.
Supply chain resilience is becoming a compliance issue where obsolete components can affect validated production.
Sustainability is moving from a brand initiative to an operational requirement.

Why medical device manufacturing is entering a new era

Medical device manufacturing is being reshaped by three main factors: smarter products, stricter regulatory expectations and more complex supply chains. Devices increasingly include software, sensors and connectivity. This means manufacturers must manage hardware, software, cybersecurity and data integrity as part of the same production strategy.

Regulatory expectations are also changing. The FDA’s Quality Management System Regulation incorporates ISO 13485:2016 by reference, bringing US quality system requirements closer to internationally recognised medical device quality management standards [3]. This reinforces the need for structured risk management, supplier controls, documentation and process validation.

For manufacturers, this creates a practical challenge. New product development must be introduced without weakening compliance or production continuity. Each process change, supplier change or software update may affect documentation, validation and quality assurance.

Digital traceability, validated automation and proactive lifecycle planning are becoming central to medical device manufacturing.

Trend 1: AI moves from experimentation to production

Artificial intelligence is one of the most significant medical device manufacturing trends in 2026. McKinsey notes that AI and generative AI can support medtech value creation by improving productivity, product development and profitability [7]. The FDA also maintains a public list of AI-enabled medical devices authorised for marketing in the US, reflecting the growing role of AI across the sector [10].

In production environments, AI-powered vision systems can support inspection of surgical instruments, catheters, diagnostic assemblies and wearable device components. These systems can identify surface defects, dimensional variation and assembly issues more consistently than manual inspection alone. This approach is particularly useful where small variations may affect product performance or compliance records.

Predictive maintenance is another practical application. Deloitte reports that predictive maintenance can increase productivity by 25%, reduce breakdowns by 70% and lower maintenance costs by 25% [5]. In medical device manufacturing, this is relevant because unplanned downtime can interrupt validated production processes and delay the supply of critical products.

AI is also entering design and regulatory workflows. Generative AI can help engineering teams compare design options, review constraints and organise technical documentation. AI outputs must still be reviewed, documented and governed by qualified personnel.

The main rollout challenge is validation. Many manufacturers find that introducing AI is less difficult than proving that it performs consistently within a regulated quality system. Training data, model drift, audit trails and human review processes should be considered before AI becomes part of inspection, maintenance or documentation workflows.

Trend 2: Smart manufacturing becomes standard practice

Smart manufacturing in medical devices is becoming an operational requirement rather than a future ambition. The World Economic Forum’s Network shows how advanced manufacturing sites are using digital technologies to improve productivity, sustainability and supply chain resilience [6].

For medical device manufacturers, Industry 4.0 technologies are most useful when they improve visibility and traceability. Industrial IoT sensors can collect data from production equipment, cleanrooms, inspection systems and environmental controls. This helps teams identify deviations before they affect product quality.

Manufacturing Execution Systems are also becoming central to compliance. An MES can record which materials, operators, equipment and process parameters were used for each production batch. If a quality issue occurs, these records can help teams investigate the root cause and identify affected products more quickly.

Digital twins provide another route to process improvement. A digital twin can model a cleanroom line, assembly process or packaging workflow before a change is introduced physically. This is useful in regulated production because it can reduce disruption to validated processes.

Smart manufacturing projects often stall when data is inconsistent, siloed or poorly governed. These factors become particularly relevant where legacy PLCs, inspection systems and quality platforms do not communicate easily. A practical deployment strategy often begins with one critical line or high-risk process before wider rollout.

Trend 3: Automation and robotics address productivity pressures

Automation in medical device manufacturing is expanding as manufacturers seek greater precision, scalability and consistency. MD+DI identifies automation, robotics and advanced manufacturing as key drivers of productivity and product development in the sector [9].

Collaborative robots can support repetitive tasks such as assembly, inspection, labelling and packaging. They are particularly useful where manufacturers produce several product variants and need flexible automation rather than a fixed, high-volume system.

Advanced robotics also support precision manufacturing. Surgical instruments, diagnostic cartridges and connected devices often require repeatable handling of small or delicate components. Automated systems can reduce variation and improve throughput, but they must be validated carefully before being introduced into regulated production.

Workforce planning is an important consideration. Automation does not remove the need for skilled employees. It changes the skills required across production, maintenance, engineering and quality teams.

Successful automation strategies combine people, processes and technology. They reduce repetitive work while giving skilled employees better tools to monitor process performance, investigate deviations and maintain production continuity.

Trend 4: Connected devices increase cybersecurity and interoperability requirements

Connected medical devices are creating new opportunities for remote monitoring, diagnostics and personalised care. IQVIA identifies interoperability and connects ecosystems as important forces shaping medtech in 2026 [11].

For manufacturers, connectivity changes product and production requirements. Devices must communicate with hospital systems, electronic health records and cloud platforms. They must also protect patient data and remain secure throughout the product lifecycle.

Cybersecurity is now a manufacturing and quality issue, not only an IT concern. FDA guidance on cybersecurity in medical devices focuses on quality system considerations and premarket submissions for cyber devices [4]. FDA FAQs also state that section 524B of the FD&C Act requires manufacturers of cyber devices to provide a software bill of materials covering commercial, open-source and off-the-shelf software components [4].

This is a significant consideration because healthcare remains a high-risk cyber environment. IBM’s 2025 Cost of a Data Breach Report found that healthcare had the highest average breach cost of any industry, at $7.42 million per incident according to reporting on the IBM/Ponemon study [8].

Manufacturers should build cybersecurity into design, supplier selection, software updates and post market monitoring. Teams should also define how software updates, vulnerabilities and supplier software components will be documented throughout the product lifecycle.

Trend 5: Quality management becomes more digital

Medical device quality management is moving away from paper-based processes towards digital systems. This shift is being driven by regulatory pressure, product complexity and the need for faster audit readiness.

Digital quality management systems can support document control, corrective and preventive actions, training records, supplier management and audit preparation. They can also help manufacturers maintain clearer links between design, production, risk management and post market data.

The FDA’s connection between QMSR and ISO 13485:2016 reinforces the importance of internationally consistent quality management [3]. For manufacturers operating across several markets, harmonised documentation and process control are becoming increasingly important.

A practical priority is to review how current procedures map to ISO 13485:2016, especially around risk management, supplier controls, documentation and corrective actions. Teams should also assess whether digital quality systems are validated, whether audit trails are complete and whether responsibilities for electronic records are clearly defined.

Digital systems do not automatically improve compliance. Poorly configured workflows can create new risks. A structured deployment plan should include software validation, user training, data ownership and clear procedures for maintaining compliant records.

Trend 6: Supply chain resilience becomes a competitive advantage

Supply chain resilience is one of the most important but under-discussed medical device manufacturing trends.

This creates practical difficulty for regulated manufacturers. If a validated production line relies on obsolete automation hardware, replacing it may require engineering review, supplier approval, software checks, installation qualification and further validation. A component shortage can therefore become both a production and compliance issue.

Obsolescence is particularly difficult because replacing a PLC, HMI, drive or control module is rarely a simple purchasing decision. Revision levels, firmware compatibility, communication protocols and installation requirements may all affect whether a replacement part is suitable. For this reason, many manufacturers treat obsolete automation parts as a quality and continuity risk, not only a maintenance issue.

Manufacturers are responding by reducing dependence on single suppliers, increasing inventory visibility and monitoring component lifecycles. Data analysis can help identify high-risk parts before shortages occur, while alternative sourcing strategies can protect production continuity.

Last-time buys, approved alternatives and trusted spare parts partners can help reduce disruption. These decisions should also be documented within risk management and quality processes so that continuity planning does not create compliance risk.

Trend 7: Sustainability moves into operations

Sustainability is becoming a business requirement across medical technology. MedTech Europe’s 2025 report highlights the sector’s economic importance and the need for long-term, responsible product development [2].

Manufacturers are reviewing materials, packaging, waste, energy use and supply chain decisions through an environmental lens. This is not only a reputation issue. Lower-waste production can reduce scrap, lower energy costs and improve resource use.

Sustainability also creates design and compliance challenges. Medical devices often require sterile packaging, strict material performance and regulatory approval. Manufacturers must balance environmental goals with safety, compliance and product performance.

The practical opportunity is to begin with operational improvements. Lower-energy equipment, lean production, waste reduction and better spare parts management can support both ESG goals and manufacturing performance.

Conclusion

The top medical device manufacturing trends in 2026 point towards a more intelligent, connected and resilient industry. AI is improving inspection and maintenance. Smart factories are increasing visibility. Automation supports precision and scalability. Connected devices are creating new opportunities, but they also raise cybersecurity and interoperability requirements.

At the same time, regulation, supply chain risk and sustainability are becoming central to long-term manufacturing strategy. Manufacturers that succeed will be those that connect new technology with compliance, lifecycle planning and operational discipline.

Technology alone will not define the future of medical device manufacturing. The practical advantage will come from using technology to build safer products, stronger processes and more resilient supply chains.

EU Automation helps source obsolete, reconditioned and hard-to-find industrial automation parts through a global supplier network, supporting planned maintenance, urgent breakdowns and long-term obsolescence management. This helps protect validated production systems, reduce disruption and maintain operational resilience.